VEPPANU commercialized as new treatment class, Rigel Pharmaceuticals reveals

Traders Union
All News
Business & Wealth
Companies
Rigel starts VEPPANU U.S. sales

Top Stories

Editors' Picks

Stocks

Crypto

Economics

Currencies

Commodities

Business & Wealth

Market Voices

Artem Shendetskii

14.08.2026

VEPPANU commercialized as new treatment class, Rigel Pharmaceuticals reveals — Rigel starts VEPPANU U.S. sales

Rigel Pharmaceuticals has announced the commercial availability of VEPPANU (vepdegestrant) in the U.S. This follows the FDA's May approval of vepdegestrant, making it the first approved therapy in a completely new treatment class.

The launch marks a significant step for Rigel Pharmaceuticals, as VEPPANU debuts in a market seeking innovative therapies for unmet medical needs. Further details on the rollout and market impact are expected to emerge in the coming months.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Rigel Pharmaceuticals recently announced its Q2 2026 financial results and scheduled a webcast for investors to discuss its latest performance. The update provided investors with insight into the company's recent financial standing. VEPPANU’s commercial release follows these company disclosures.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

Editor's Picks for You

Google loses billions: What’s behind Alphabet’s stock crash?

By Oleg Tkachenko
15 min ago

Google loses billions: What’s behind Alphabet’s stock crash?

Editors' Picks

The end of Bitcoin’s growth era: Why prominent investors doubt its future

By Olena Litvinenko
20 hours ago

The end of Bitcoin’s growth era: Why prominent investors doubt its future

Editors' Picks

WeFi CEO: Banks are overstating the threat from stablecoins

By Eugene Komchuk
22 hours ago

WeFi CEO: Banks are overstating the threat from stablecoins

Editors' Picks

All Editors' Top Picks

Latest Rigel News

Rigel Pharmaceuticals to unveil RET fusion-positive tumor findings at ESMO 2026

By Oksana Koneva
20.10.2026

Rigel Pharmaceuticals to unveil RET fusion-positive tumor findings at ESMO 2026

Companies

Rigel Pharmaceuticals partners with PDSA_ITP for ITP awareness campaign this month

By Eugene Komchuk
01.09.2026

Rigel Pharmaceuticals partners with PDSA_ITP for ITP awareness campaign this month

Companies

Rigel Pharmaceuticals posts Q2 2026 earnings and schedules results webcast

By Ivan Andriyenko
04.08.2026

Rigel Pharmaceuticals posts Q2 2026 earnings and schedules results webcast

Companies

Oleg Tkachenko
15 min ago

Google loses billions: What’s behind Alphabet’s stock crash?

Olena Litvinenko
20 hours ago

The end of Bitcoin’s growth era: Why prominent investors doubt its future

Eugene Komchuk
22 hours ago

WeFi CEO: Banks are overstating the threat from stablecoins

Dmytro Kharkov
Yesterday

HSBC’s warning signs point to a bigger risk for global banks

Anastasiia Chabaniuk
Yesterday

Why do crypto companies want their own banks?

Elena Nikulina
4 min ago

European investment could surge in Hong Kong and China amid unrest, Mario Nawfal notes

Alena Volkova
18 min ago

New state pension tax allowance graphic is in progress, Martin Lewis notes

Hanna Syniavska
18 min ago

Sjuul Follings: Midnight and Sig Network merge to enhance privacy on Ethereum

Mikhail Vnuchkov
48 min ago

Tokenized securities discussed in interview, Savino Vaness states

Yulia Slavina
48 min ago

Quinten Francois: U.S. fiscal 2026 deficit reached $1.99 trillion

Top News

Iryna Sazhynska
18 min ago

ING shares fall as bank plans job cuts

ING shares fall as bank plans job cuts

Hanna Syniavska
1 hour ago

Warsh keeps December rate hike in play as Fed holds steady

Warsh keeps December rate hike in play as Fed holds steady

Olga Shendetskaya
17 hours ago

Bank of Canada raises rates for first time in over three years

Bank of Canada raises rates for first time in over three years

Eugene Komchuk
18 hours ago

Google develops a Bitcoin custody service

Google develops a Bitcoin custody service

Andrey Mastykin
18 hours ago

Oil prices jump amid new threats to Saudi energy infrastructure

Oil prices jump amid new threats to Saudi energy infrastructure

Top 5 companies for you

United States

Live News

Mykhailo Ihnatenko
Now

Ethereum price faces $2,200 risk as early holder activity and ETF outflows weigh

Eugene Komchuk
Now

CFTC chair says refrigerators could one day launch memecoins

Aleksandra Chaikina
Now

DTCC launches securities tokenization service with JPMorgan and Citi

Anton Kharitonov
Now

EUR/USD remains under pressure near 1.1125 ahead of Fed rate decision

Hanna Syniavska
Now

Turkey cancels Tera Yatirim license amid $100 billion market rout

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.